Trial Profile
The Change of focal macular electroretinogram(ERG) in patients with age-related macular degeneration after intravitreal aflibercept(IVA).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 19 Aug 2016 New trial record